WuXi AppTec Co., Ltd. is a leading pharmaceutical company based in China that offers a wide range of research and manufacturing services in the healthcare industry. With a focus on environment, sustainability, and governance (ESG), the company has a low risk rating score of 10.9. WuXi AppTec provides services for small-molecule drugs, cell therapies, gene therapies, and medical device testing. The company operates in various segments such as WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. While its geographic areas include the USA, Europe, and the Rest of the world, WuXi AppTec generates the majority of its revenue from the USA.